Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Trulieve Opens New Medical Cannabis Dispensary in Milton, West Virginia


Grand opening celebration event on Sept. 24

TALLAHASSEE, Fla., Sept. 24, 2022 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of its newest West Virginia dispensary in Milton at 5 Perry Morris Square. The Milton dispensary will open its doors on Sept. 24 at 10 a.m. EDT for patients, with ongoing hours of 10 a.m. to 8 p.m. from Monday through Saturday, and 10 a.m. to 6 p.m. on Sunday.

Grand opening festivities held throughout the day will include partner giveaways, DJs, food trucks, deals and specials, as well as all registered patients will receive a 25% discount. On-site medical care specialists will be available to assist with medical card registration and certification for West Virginia patients.

"We are very excited to expand our West Virginia presence to include a location in Milton, and we look forward to serving patients in the surrounding area,'' said Trulieve CEO Kim Rivers. "Our West Virginia team has proven to be incredibly passionate and accommodating, and we are eager to offer our personalized patient care to more patients in the state."

Trulieve patients across West Virginia can choose from a large selection of THC and CBD products available in a variety of consumption methods, including flower, concentrates, tinctures, topicals, ingestibles, and more. Designed to meet every patient's needs, our portfolio of in-house brands includes Cultivar Collection, Momenta, Muse, TruFlower and more.

Trulieve operates medical dispensaries across West Virginia in Belle, Milton, Hurricane, Parkersburg, South Charleston, Weston, and two locations in Morgantown, with plans to open an additional dispensary location by the end of the year in Huntington.

For more information on store locations, please visit https://www.trulieve.com/dispensaries/west-virginia.

About Trulieve

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve 

Investor Contact 
Christine Hersey, Executive Director of Investor Relations 
+1 (424) 202-0210 
[email protected]  

Media Contact 
Rob Kremer, Executive Director of Corporate Communications 
+1 (404) 218-3077 
[email protected] 

SOURCE Trulieve Cannabis Corp.


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: